CRISPR Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR technology. Its pipeline spans multiple disease areas, including hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. The company advanced the first CRISPR-based gene-editing therapy into clinical testing in 2018, and exagamglogene autotemcel (exa-cel) was approved in several countries starting in late 2023 for sickle cell disease and transfusion-dependent beta-thalassemia. CRISPR Therapeutics is headquartered in Zug, Switzerland, with a U.S. subsidiary and R&D operations in Boston and San Francisco. It collaborates with other industry players, including Vertex Pharmaceuticals, as part of its strategy to expand development and reach.
1-888-653-2347 
support@leadiq.com 
